Trial Profile
Influence of escitalopram on somatosensory processing in patients with major depression.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Pharmacodynamics
- 13 Apr 2015 Status changed from recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov
- 01 Jun 2011 Planned end date changed from 1 Dec 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 28 Jan 2009 Planned end date changed from Dec 2009 to Dec 2010 as reported by ClinicalTrials.gov.